hemophilia

Catalyst gives positive hemophilia update as 2 more subjects complete study
Biopharma Dive
Thu, 08/16/18 - 06:47 pm
Catalyst Bioscences
hemophilia
clinical trials
What's Next for Spark Therapeutics
Motley Fool
Wed, 08/15/18 - 09:50 am
Spark Therapeutics
hemophilia
SPK-8011
A bad week for these two biotechs
Motley Fool
Sun, 06/24/18 - 10:06 am
Anika Therapeutics
CINGAL
Catalyst Biosciences
CB 2679d
hemophilia
FDA plans to speed path to approval for some gene therapies, starting with hemophilia
Stat
Tue, 05/22/18 - 06:38 pm
FDA
drug approvals
gene therapies
Scott Gottlieb
hemophilia
Roche flags first case of anti-drug antibodies that forced a patient to drop would-be blockbuster Hemlibra
Endpoints
Thu, 04/26/18 - 11:11 am
Roche
hemophilia
Hemlibra
anti-drug antibodies
Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing
Fierce Pharma
Tue, 04/17/18 - 11:33 am
Roche
Hemlibra
hemophilia
FDA
breakthrough status
ICER
Novo charts course for sickle cell amid headwinds in hemophilia
Biopharma Dive
Thu, 04/5/18 - 11:47 pm
Novo Nordisk
sickle cell disease
hemophilia
EPI01
EpiDestiny
Under fire for 5 deaths of patients taking Hemlibra, Roche spills details
Fierce Pharma
Fri, 03/30/18 - 05:56 pm
Hemlibra
Roche
hemophilia
Hemophilia groups warned of 5 deaths among patients taking Roche’s big new blockbuster Hemlibra
Endpoints
Tue, 03/27/18 - 10:13 pm
hemophilia
Roche
Hemlibra
Sanofi Leads the Hemophilia Space on Bioverativ Acquisition
Market Realist
Wed, 02/7/18 - 10:56 pm
Sanofi
hemophilia
Bioverativ
M&A
Sanofi to Buy Biogen Hemophilia Spinoff for $11.6 Billion
Bloomberg
Mon, 01/22/18 - 11:05 am
Sanofi
M&A
Bioverativ
Biogen
hemophilia
Shire's latest approval won't save it from Hemlibra
Biopharma Dive
Wed, 01/17/18 - 09:58 pm
Shire
Hemlibra
Adynovi
hemophilia
Europe
Adynovate
Shire looks to stall Hemlibra impact with court injunction
BioPharma Dive
Tue, 12/19/17 - 12:03 pm
Shire
Hemlibra
Roche
hemophilia
Alnylam, Sanofi given the all-clear to resume fitusiran trials
BioPharma Dive
Sun, 12/17/17 - 10:24 am
Alnylam
Sanofi
clinical trials
fitusiran
hemophilia
Shire CEO: Hemophilia will remain a core business
BioPharma Dive
Mon, 12/11/17 - 09:49 am
Shire
Pharma CEOs
hemophilia
Flemming Ornskov
Disruption of the Year: Long-Acting Hemophilia Drugs
BioPharma Dive
Tue, 12/5/17 - 09:34 am
hemophilia
Eloctate
Kovaltry
Bayer
Bioverativ
Startup seeking to resurrect Vioxx, arthritis drug pulled from market
Stat
Tue, 11/21/17 - 09:53 am
Vioxx
Merck
hemophilia
Tremeau Pharmaceuticals
On Eve of Big Data Reveal, Patient Death Stalls Alnylam Hemophilia Drug
Xconomy
Thu, 09/7/17 - 05:46 pm
Alnylam
fitusiran
hemophilia
Bioverativ and Bicycle keep rare disease deals rolling
BioPharma Dive
Thu, 09/7/17 - 09:39 am
Bioverativ
Bicycle Therapeutics
R&D
drug development
sickle cell disease
hemophilia
Pfizer puts hemophilia spin on ultrapopular Minecraft to educate young patients
Fierce Pharma
Wed, 09/6/17 - 08:42 pm
Pfizer
hemophilia
patients

Pages